Humacyte, Inc. Files 8-K Report
Ticker: HUMAW · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1818382
| Field | Detail |
|---|---|
| Company | Humacyte, Inc. (HUMAW) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting, corporate-filing
Related Tickers: HUMA
TL;DR
HUMA filed an 8-K, mostly routine stuff, no major news.
AI Summary
On March 25, 2025, Humacyte, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company, formerly known as Alpha Healthcare Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates routine corporate reporting by Humacyte, Inc., providing updates on its operational and financial disclosures to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any significant new risks or material adverse events.
Key Players & Entities
- Humacyte, Inc. (company) — Registrant
- Alpha Healthcare Acquisition Corp. (company) — Former Company Name
- March 25, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for Humacyte, Inc.?
The filing is primarily for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate reporting.
When was this 8-K report filed?
The report was filed on March 25, 2025.
What was Humacyte, Inc.'s former company name?
Humacyte, Inc.'s former company name was Alpha Healthcare Acquisition Corp.
In which state is Humacyte, Inc. incorporated?
Humacyte, Inc. is incorporated in Delaware.
What is Humacyte, Inc.'s Standard Industrial Classification (SIC) code?
Humacyte, Inc.'s SIC code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Humacyte, Inc. (HUMAW).